Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288032919> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4288032919 endingPage "400" @default.
- W4288032919 startingPage "399" @default.
- W4288032919 abstract "Extra-lipid effects of ezetimibe, a new lipid-lowering agent, are so far poorly understood.Twenty-two patients with elevated total and LDL cholesterol levels, statin-intolerant or having contraindications to statin therapy, were treated with ezetimibe (10 mg daily) for 90 days. Plasma levels of lipids, apolipoproteins, glucose homeostasis markers, leptin, adiponectin, visfatin, tumor necrosis factor-α (TNF-α), free fatty acids (FFA) and high sensitivity C-reactive protein (hsCRP) were examined at the beginning of the study and after 30 and 90 days of treatment.Compared with the control age-, sex-, and weight-matched healthy subjects, isolated hypercholesterolemic patients exhibited higher plasma levels of leptin, visfatin and TNF-α and lower plasma levels of adiponectin. Their baseline FFA and hsCRP levels were also increased. Ezetimibe decreased circulating levels of total cholesterol, LDL cholesterol and apolipoprotein B-100. The drug significantly reduced plasma levels of visfatin and only tended to reduce plasma levels of leptin, TNF-α, visfatin, FFA and CRP. The effect of ezetimibe on these markers was lipid-independent but stronger in insulin-sensitive than in insulin-resistant patients.The obtained results indicate that the presence of isolated hypercholesterolemia is associated with abnormal hormonal function of the adipose tissue. They also show that ezetimibe induces relatively small changes in adipose tissue hormonal function and systemic inflammation in patients with elevated cholesterol levels." @default.
- W4288032919 created "2022-07-27" @default.
- W4288032919 creator A5010978866 @default.
- W4288032919 creator A5012744868 @default.
- W4288032919 creator A5028544979 @default.
- W4288032919 creator A5080813710 @default.
- W4288032919 date "2022-08-01" @default.
- W4288032919 modified "2023-09-27" @default.
- W4288032919 title "Ceftobiprole, a new option for multidrug resistant microorganisms in the outpatient antimicrobial therapy setting" @default.
- W4288032919 cites W2961779122 @default.
- W4288032919 doi "https://doi.org/10.1016/j.eimce.2021.05.017" @default.
- W4288032919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35906034" @default.
- W4288032919 hasPublicationYear "2022" @default.
- W4288032919 type Work @default.
- W4288032919 citedByCount "1" @default.
- W4288032919 countsByYear W42880329192023 @default.
- W4288032919 crossrefType "journal-article" @default.
- W4288032919 hasAuthorship W4288032919A5010978866 @default.
- W4288032919 hasAuthorship W4288032919A5012744868 @default.
- W4288032919 hasAuthorship W4288032919A5028544979 @default.
- W4288032919 hasAuthorship W4288032919A5080813710 @default.
- W4288032919 hasConcept C126322002 @default.
- W4288032919 hasConcept C134018914 @default.
- W4288032919 hasConcept C171089720 @default.
- W4288032919 hasConcept C194832188 @default.
- W4288032919 hasConcept C2776782570 @default.
- W4288032919 hasConcept C2777391703 @default.
- W4288032919 hasConcept C2778163477 @default.
- W4288032919 hasConcept C2778657065 @default.
- W4288032919 hasConcept C2779306644 @default.
- W4288032919 hasConcept C2780613262 @default.
- W4288032919 hasConcept C511355011 @default.
- W4288032919 hasConcept C71924100 @default.
- W4288032919 hasConceptScore W4288032919C126322002 @default.
- W4288032919 hasConceptScore W4288032919C134018914 @default.
- W4288032919 hasConceptScore W4288032919C171089720 @default.
- W4288032919 hasConceptScore W4288032919C194832188 @default.
- W4288032919 hasConceptScore W4288032919C2776782570 @default.
- W4288032919 hasConceptScore W4288032919C2777391703 @default.
- W4288032919 hasConceptScore W4288032919C2778163477 @default.
- W4288032919 hasConceptScore W4288032919C2778657065 @default.
- W4288032919 hasConceptScore W4288032919C2779306644 @default.
- W4288032919 hasConceptScore W4288032919C2780613262 @default.
- W4288032919 hasConceptScore W4288032919C511355011 @default.
- W4288032919 hasConceptScore W4288032919C71924100 @default.
- W4288032919 hasIssue "7" @default.
- W4288032919 hasLocation W42880329191 @default.
- W4288032919 hasLocation W42880329192 @default.
- W4288032919 hasOpenAccess W4288032919 @default.
- W4288032919 hasPrimaryLocation W42880329191 @default.
- W4288032919 hasRelatedWork W1964378492 @default.
- W4288032919 hasRelatedWork W1986880059 @default.
- W4288032919 hasRelatedWork W2048572539 @default.
- W4288032919 hasRelatedWork W2055437256 @default.
- W4288032919 hasRelatedWork W2066062695 @default.
- W4288032919 hasRelatedWork W2070380430 @default.
- W4288032919 hasRelatedWork W2078496896 @default.
- W4288032919 hasRelatedWork W2135360268 @default.
- W4288032919 hasRelatedWork W2299241988 @default.
- W4288032919 hasRelatedWork W2591751159 @default.
- W4288032919 hasVolume "40" @default.
- W4288032919 isParatext "false" @default.
- W4288032919 isRetracted "false" @default.
- W4288032919 workType "article" @default.